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Limitations of the death certificate only index as a measure of
incompleteness of cancer registration
H Brenner
Department ofEpidemiology, University of Ulm, Germany.
Summary The death certificate only (DCO) index, which quantifies the proportion of patients for whom the
death certificate provides the only notification to the registry, is a widely used measure of incompleteness of
population-based cancer registration. This paper provides an algebraic assessment and a quantitative illustra-
tion of the relationship between the DCO index and incompleteness of cancer registration. It is shown that the
relationship between the DCO index and incompleteness of registration is strongly dependent on the case
fatality rate and the misclassification rates of cancer deaths among unregistered patients. Therefore, the
DCO index is a very poor indicator ofincompleteness. Similar limitations apply to the DCN index (proportion
of cases first notified by death certificate), which has been proposed as an alternative measure of incomp-
leteness.
Keywords: death certificate; cancer registry; disease surveillance; epidemiological method
Population-based cancer registries are most valuable tools of
both descriptive and analytical cancer epidemiology. Exhaus-
tive ascertainment of all cases can rarely be achieved, how-
ever, on the population level. Therefore, attempts to quantify
the degree of underascertainment are essential for proper
interpretation of cancer registry data.
Various approaches have been proposed to quantify
incompleteness of population-based cancer registration
(Freedman, 1978; Goldberg et al., 1980; Benn et al., 1982;
Devesa et al., 1984; Shanmugaratnam, 1989; Jensen et al.,
1991; Parkin et al., 1992). A particularly widely used indirect
measure of incompleteness is the death certificate only index
(DCO index) which quantifies the proportion of cases for
whom the death certificate is the only source of notification.
For example, the DCO index is routinely reported as an
indicator of incompleteness in international cancer incidence
statistics published by the International Agency for Research
on Cancer (Parkin et al., 1992).
One of the major reasons for the popularity of the
DCO index is its ease of calculation in situations in which
death certificates are routinely linked with registry data.
Nevertheless, the DCO index has a variety of limitations, the
best known being its dependence on case fatality rates: poor
completeness may go along with a low DCO index for
cancers which have low case fatality rates. Another major
limitation of the DCO index is its sensitivity to the well-
documented inaccuracies of the certified causes of death
(Barclay and Phillips, 1962; De Faire et al., 1976; Percy et
al., 1981). As an example, endometrial cancer is often mis-
classified as cervical cancer, and vice versa, on death
certificates, and similar misclassification problems have also
been documented for other cancers, such as colon and rec-
tum cancer (Percy et al., 1981). Furthermore, non-specific
codes, such as cancer of unknown site, are frequently used on
death certificates, and cancer often remains undetected as the
underlying cause of death among elderly patients. While
these limitations have been widely recognised, systematic
quantitative work is lacking on their impact on the value of
the DCO index as an indicator of incompleteness.
In the present paper, a simple algebraic framework is
provided for such an assessment, and the relation between
the DCO index and incompleteness of cancer registration is
investigated as a function of its major determinants. The
results are numerically illustrated for practically relevant
ranges of values of these determinants.
Correspondence: H Brenner, Abt. Epidemiologie, Universitat Ulm,
Albert-Einstein-Alle 43, D-89081 Ulm, Germany
Received 1 August 1994; revised 20 February 1995; accepted 6
March 1995
Unfortunately, there has been a lack of uniformity and
some confusion in the use of the term 'death certificate only'
and in reporting of cancer incidence data (Parkin et al.,
1992). A minority of cancer registries do not include
DCO cases in tabulations of cancer incidence. Some cancer
registries make efforts to get additional notifications from
other sources when they receive a death certificate of a
previously unnotified case. For example, an additional
notification on the deceased individual is often requested
from the doctor who fills out the death certificate. This
strategy helps to obtain more comprehensive and accurate
information on these patients. It has been argued that such
'secondary' notifications should be excluded when estimating
completeness of cancer registration (Benn et al., 1982), and
an alternative index, the 'DCNindex' (proportion of cases
first notified by death certificates) has been proposed to
characterise incompleteness in such situations (Parkin et al.,
1992). The algebraic model provided in this paper is equally
applicable to both the DCO index and the DCN index, but
the main focus of the paper is on the DCO index, which is
more frequently reported by cancer registries.
Definitions and algebraic framework
Let DCO and INC denote the DCO index and the level of
incompleteness of a registry respectively. DCO cases are
assumed to be included in incidence calculations, and
incompleteness is defined here as the proportion of cancer
cases missed by both death certificates and notifications by
other sources. Let P. be the probability of ascertainment of
patients by sources other than the death certificate (diag-
nosed at life or post mortem), and let Pd be the probability
of death due to the cancer of interest ('case fatality rate')
among cancer patients for whom no notification other than
the death certificate is made ('unregistered cases') respectively
(if the model is applied to the DCN index, PO is defined as
the probability that a primary notification is made by a
source other than the death certificate and Pd is defined as
the case fatality rate among patients for whom no such
primary notification is made).
I will first address the relationship of DCO and INC with
the individual ascertainment rates by death certificates and
other sources that would be expected if both types of sources
were free of diagnostic error. In addition, the following
assumptions are made:
(1) Notifications through death certificates are com-
plete among patients who die from cancer.
(2) PO and Pd are approximately stable over time.
Assumption (2) allows the time lag between diagnosis ofCompleteness of cancer registration
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cancer and death from cancer to be neglected in patients
notified by death certificate only.
Under these assumptions, the following two fractions of
the eligible cases are expected to be registered: a fraction PO
of cases notified by sources other than the death certificate
(with or without an additional notification by death
certificate) and a fraction Pd (1 - P.) of cases notified by
death certificate only (if the DCN index is used, this latter
fraction denotes the proportion of cases first notified by
death certificate). Hence, expected incompleteness of registra-
tion is given as
INC = 1-[Po
+ Pd (1 -P.)] (1)
while the expected DCO index is given as
DCO = Pd(l - Po)/[Po+ Pd (1 Po)] (2)
It can easily be seen that a decrease in PO, the probability
of ascertainment by sources other than the death certificate,
increases both the expected incompleteness (whenever Pd<1)
and the expected DCO index. A decrease in the case fatality
rate among unregistered cases Pd also increases expected
incompleteness. At the same time, however, it decreases the
expected DCO index whenever PO<1, which seriously hinders
the use of the DCO index as an indicator of incompleteness.
The following relationship between DCO and INC can easily
be derived from equations (1) and (2):
DCO = Pd (1- PO)/(l - INC)
Pd INC/[Cl - INC)C1- Pd)]
INC= 1-Pd (1-PP)/DCO (3)
or, equivalently,
= 1- Pd/[DCO + Pd(l - DCO)J (4)
I will now address the additional problem of mis-
specification of cancer diagnoses on death certificates. For
simplicity, it is assumed that diagnoses obtained from other
sources of notification are free of diagnostic error. It is
further assumed that false-negative and false-positive diag-
noses on death certificates are 'corrected' for individuals also
notified by one or more source(s) other than the death
certificate: it is common practice that these individuals are
registered exclusively under the diagnosis given in those other
sources which are usually considered to be more valid. For
example, a patient who has been notified to a cancer registry
by a gynaecologist with a diagnosis of cervical cancer during
her lifetime will be registered with this diagnosis only, even if
endometrial cancer is later stated as the underlying cause of
death on the death certificate. This implies that the expected
numbers of cases also notified by other sources are unaffected
by false-positive and false-negative diagnoses on the death
certificate. No such 'correction' is possible, however, for
individuals notified by the death certificate only.
Letfn denote the probability of false-negative diagnoses on
death certificates among otherwise unregistered individuals
who die of the cancer of interest, and let fp denote the
expected occurrence of false-positive diagnoses, expressed in
units of the expected occurrence of true-positive diagnoses
among DCO cases (if the DCN index is used, fn and fp
denote the misclassification rates among DCNcases).
Under these assumptions, the expected incompleteness of
registration is given as
INC = 1-[PO + Pd(l-fn) (I1-Pj] (S)
while the expected DCO index is given as
DCO = Pd(I +fp-fn)(I -PO)/
[P. + Pd(l +fp-fn)(l
- P)] (6)
Note that false-positive diagnoses are not included in the
calculation of (in)completeness. Expected incompleteness in-
creases, however, with false-negative diagnoses. In contrast,
the expected DCO index is modified by false-positive and
false-negative diagnoses. Iffp exceedsfn, then the DCO index
is increased; iffn exceedsfp, then the DCO index is reduced
by the occurrence of misdiagnoses.
Although the relation between DCO and INC is somewhat
more complex in the presence of misdiagnoses, simple algeb-
raic transformations of equations (5) and (6) lead to the
following relationships between INC and DCO:
INC = [DCO(l - Pd + PJf,)]/[DCO + Pd(l +ffp-f,,)
(1-DCO)]
and
DCO = PdINC(l +fp-f,,)/[l - Pd + Pdfn-
INC + PdINC(l +fp-fn)]
(7)
(8)
Numerical illustration
For the numerical illustrations, relevant values of Pd, fp and
fn need to be delineated. Numerous studies have investigated
case fatality rates of cancer patients and misclassification
rates of cancer deaths on death certificates. As an example,
approximate estimates of case fatality rates are given in
Table I, which were derived as 1 minus 5 year cumulative
relative survival rates, as reported by Logan (1978) for
women in the United States whose cancer was diagnosed in
1965-69. The relative survival rates reflect the excess mor-
tality due to cancer rather than total (absolute) mortality of
cancer cases. They are derived in such a way that they are
unaffected by the validity of causes of death on death
certificates (Ederer et al., 1961). The 1 minus 5 year
cumulative relative survival rates closely approximate cancer
site-specific case fatality since excess mortality is close to zero
5 years after diagnosis for most forms of cancer. Table I also
provides examples of misclassification rates of cancer deaths
derived from a detailed investigation on the accuracy of
cancer death certificates in the United States 1969-71 by
Percy et al. (1981).
Case fatality rates strongly vary between cancer sites.
Estimates derived from Logan (1978) are highest for cancer
of the pancreas (0.98), the liver (0.92), the lung (0.88) and the
stomach (0.86). Case fatality rates are much lower for other
cancers, such as endometrial cancer, and even more so for
some cancers not listed in Table I, such as non-melanoma
skin cancer, which has a case fatality rate close to zero. Rates
of false-positive and false-negative diagnoses also show
strong variation between cancer sites. In the study by Percy
et al. (1981), misdiagnoses were rare for breast cancer. The
highest rates of false-positive diagnoses were found for liver
cancer (0.67, mostly because of frequent misclassification of
liver metastases as primary liver cancer) and endometrial
cancer (0.32, owing to frequent misclassification of cervical
cancer), and the highest rate of false-negative diagnoses was
found for rectum cancer (0.44, owing to frequent misclas-
sification as colon cancer).
While previous studies including the examples given in
Table I reflect case fatality and misclassification rates among
registered patients or patients identified in cancer surveys,
comprehensive quantitative studies of these rates among
unregistered patients are lacking. It appears reasonable to
Table I Estimates of the case fatality rate and of rates offalse-positive
and false-negative diagnoses for common sites of cancer, derived from
population-based studies in the United States (Logan, 1978; Percy et al.,
1981)
Site Casefatality False positive False negative
Stomach 0.86 0.09 0.11
Colon 0.54 0.24 0.11
Rectum 0.58 0.09 0.44
Liver 0.92 0.67 0.18
Pancreas 0.98 0.11 0.10
Larynx 0.41 0.29 0.20
Lung 0.88 0.06 0.05
Breast 0.36 0.02 0.05
Cervix uteri 0.44 0.08 0.21
Corpus uteri 0.26 0.32 0.19
Ovary 0.68 0.12 0.12
Bladder 0.40 0.06 0.09
Kidney 0.56 0.07 0.12
Brain 0.68 0.12 0.03Completeness of cancer registration
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assume that among unregistered patients, who are concent-
rated in the older age groups, both case fatality rates and
misclassification rates of causes of death are higher than
among other patients. Thus, the examples given in Table I
should be regarded as providing lower limits of practically
relevant values of the parameters of interest.
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Figure 1 Relationship between incompleteness of registration
(INC) and the DCO index (DCO) as a function of the case
fatality rate among unregistered patients (Pd) in the absence of
misclassification of cancer deaths.
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Figure 1 illustrates the relationship between INC and the
DCO index as a function of the case fatality rate Pd in
unregistered patients (which is varied over a wide range
between 0.05 and 0.90) that would be expected if
classification of cancer deaths was perfect. The figure demon-
strates the extreme dependency of the DCO index on Pd for
given levels of INC and vice versa.
Only for cancers with a case fatality rate of about 40%
among unregistered patients would the level of incomp-
leteness approximately equal the value of the DCO index.
Incompleteness would be much higher than the DCO index
for cancers with lower case fatality rates, and much lower
than the DCO index for cancers with higher case fatality
rates among unregistered patients. For example, a
DCO index of 0.05 would correspond to 0.6% incomp-
leteness for a cancer with a case fatality rate of 90% among
unregistered patients, but to almost 50% incompleteness for
a cancer with a case fatality rate of 5% among unregistered
patients.
Figures 2 and 3 illustrate the impact of false-negative and
false-positive cancer diagnoses on the relationship between
the DCO index and incompleteness of registration. f, andfp
are varied between 0 and 0.50 to reflect a broad range of
potentially relevant values.
Figure 2 demonstrates the effects of false-negative diag-
noses in the absence of false-positive diagnoses. It can be
seen that the DCOindex very strongly decreases with the
rate of false-negative diagnoses for given values of INC and
Pd. Thus, DCO rates can be deceptively low even for highly
fatal cancers if the rate of false-negative diagnoses is high.
Opposite effects are expected from false-positive diagnoses
in the absence of false negative diagnoses (Figure 3). False-
positive diagnoses tend to increase the DCO index for given
levels ofincompleteness and given levels ofcase fatality rates.
While this phenomenon occurs at all levels of Pd, the effects
DCO
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Figure 2 Relationship between incompleteness of registration (INC) and the DCO index (DCO) as a function of the case fatality
rate (Pd) and the rate of false-negative cancer diagnoses (fn) among unregistered patients.of false-positive diagnoses are somewhat more limited in size
than the effects of false-negative diagnoses.
As shown in Table I, false-negative and false-positive diag-
noses typically occur in combination. In that case, their
effects will partly cancel out, and their net effect will depend
on the relative magnitude of both types of error.
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Figure 3 Relationship between incompleteness of registration
(INC) and the DCO index (DCO) as a function of the case
fatality rate (Pd) and the rate of false-positive cancer diagnoses
(fp) among unregistered patients.
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Discussion
The present paper illustrates that the DCO index is a very
poor indicator of incompleteness of cancer registration. The
DCO index strongly depends on the case fatality rate and the
misclassification rates of cancer deaths among unregistered
patients. Case fatality rates and misclassification rates of
cancer deaths show considerable variation between cancer
sites among registered patients. They are typically unknown
for unregistered patients. This seriously hinders reliable
translation of the DCOindex into an absolute measure of
completeness in most instances. Nevertheless, the DCO index
may be of some limited use as a relative measure, if compar-
ing completeness of registration for malignancies with similar
case fatality rates and similar levels of accuracy of cancer
death certificates of unregistered patients.
For example, one might consider using the DCO index to
rank completeness of cancer registration with respect to a
specific type of cancer between cancer registries in popula-
tions with similar registration practices and similar case
fatality rates. The DCO index should not be used, however,
to compare completeness of cancer registration for different
types of cancer within a registry, given the large variation in
case fatality rates between cancers. Comparison of the
DCO index for all forms of cancer between registries is also
problematic if there is strong variation in the spectrum of
cancer diagnoses. Similarly, uncritical use of the DCO index
for monitoring completeness over time is discouraged if there
are changes in case fatality rates. Since case fatality rates
tend to decrease rather than increase over time in most
countries, a constant DCO index would typically reflect
decreasing rather than increasing completeness of cancer
registration.
Variation in rates of false-positive and false-negative diag-
noses of unregistered patients further distracts from the use
of the DCO index for monitoring incompleteness of cancer
registration between cancer registries or over time. The prob-
lem can be limited to some extent by combining cancer sites
between which misclassification is common, such as colon
and rectum cancer or cervical and endometrial cancer. Diag-
nostic misclassification is usually of minor concern if the
focus is on all cancers rather than site-specific cancers.
An additional methodological issue not addressed in the
present paper also requires careful consideration in the inter-
pretation of the DCO index. There is usually a time lag of
various length between cancer diagnosis and death from the
cancer. This time lag can range between a few days and
many years for various types of cancer. Nevertheless, the
date of death is typically recorded as date of diagnosis for
DCO cases. This imprecision may be negligible whenever
there are no major temporal changes in the proportion of
DCO cases, but may further reduce the value of the
DCO index as an indicator of incompleteness otherwise. The
problem is of particular concern during the first few years of
operation of a new cancer registry, since there is typically a
rapidly decreasing proportion of DCO cases whose cancer
has been diagnosed before the beginning of registration.
The limitations of the DCO index underline the need for
better approaches to assess incompleteness of cancer registra-
tion. A variety of alternative proposals to assess incomp-
leteness of cancer registration has been made, a full discus-
sion of which would be beyond the scope of this paper.
A commonly used index is the mortality/incidence ratio
(Coleman and Demaret, 1988; Jensen et al., 1991; Parkin et
al., 1992). Obviously, this index shares the major limitation
of the DCO index, the dependency on the case fatality rate
and on the inaccuracy of death certificates.
The limitations of the DCO index outlined in the present
paper equally apply to the DCO index (proportion of cases
first notified by death certificates), which has been proposed
as an alternative measure of incompleteness. The relation of
the DCN index and incompleteness depends on case fatality
rates and misclassification rates of cancer deaths among
patients for whom no primary notification by sources other
than the death certificate is made. For these patients, mis-
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classification rates of cancer deaths will typically be somew-
hat lower than for DCO cases though, since misdiagnoses
can be corrected among those patients for whom a follow-
back notification by other sources is obtained.
The conceptually simplest and most definitive method to
check completeness of cancer registration is to identify a
series of cases from an independent source, e.g. lists of
probands in clinical trials or other research studies, and to
assess how many have been registered (Goldberg et al., 1980;
Nwene and Smith, 1982; Mattson et al., 1985; Hunt and
Coleman, 1987; Villard-Mackintosh et al., 1988; Swerdlow et
al., 1993; Schouten et al., 1993). Such independent lists are
often unavailable, however. Therefore, this approach can
rarely be employed for routine comparisons of completeness
of registration between registries.
Recently, capture-recapture methods have attracted much
interest as yet another approach to estimate completeness of
disease monitoring (Wittes et al., 1974; Robles et al., 1988;
Hilsenbeck et al., 1992; McCarty et al., 1993; Brenner, 1995;
Brenner et al., 1995). The principle is to estimate the number
of missed cases by the degree of overlap between multiple
incomplete sources of case ascertainment. Although it is still
too early for definitive judgement, this methodology appears
to be promising and should be further developed.
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